The global urology devices market is segmented by product, disease, end user, and regions. By product, the market is segmented into instruments and consumables & accessories. The instruments segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the increasing adoption of minimally invasive techniques in urology treatment and advances in technology to develop novel instruments.
The Urology Devices Market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212
By product, the urology devices market is classified into instruments and consumables & accessories. The instruments segment is expected to lead the global urology devices market in 2017.
By disease, the market is segmented into kidney disease, urological cancer and BPH, pelvic organ prolapse. The kidney diseases segment is expected to account for the largest share of the global urology devices in 2017. A large number of products are used in the diagnosis and treatment of this segment which is a major factor responsible for the dominant share of this segment.
On the basis of end user, the urology devices market is categorized into hospitals and clinics, dialysis centers, and other end users.
Based on region, the urology devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the urology devices market in 2017.
Top Key Players:
Key players in the urology devices market include Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and Biolitec (Germany).